Skip to the main content.

Science Driven.
Customer Focused.

A Global CDMO Providing Innovative Biologic Solutions.

As the icon of next-generation CDMOs, KBI Biopharma is driving breakthroughs in biopharmaceutical development and manufacturing that positively impact the lives of patients worldwide.

 
 

Announcing the Operational Consolidation of KBI & Selexis to Operate as One Organization, Providing a Seamless Experience for Partners

Learn More

kbi-biopharma-globe-2

kbi-biopharma-info-1

KBI is Redefining Contract, Comprehensive, Cutting-Edge, Collaborative, Complete, Consistent, Compliant, Critical, Connected, Cohesive, Capable

Development and Manufacturing Services for New Biologics

Next-Generation CDMO Services Supporting the Development and Manufacturing of New Biopharmaceuticals

Featuring the KBI

SUREtechnology Platform™

powered by Selexis® for premium, stable, and integrated CHO-based CLD.

Versatile      Scalable      Efficient

Explore our services
promo-modalities-ma-1

Connect with KBI Biopharma

Featuring the KBI

PUREplatform™

A new standard of E. Coli expression for clean, efficient therapeutic protein production.

Increased Efficiencies
Exceptional Quality
Engineered for Commercial Use

Explore our services
promo-modalities-mi

Mammalian

Comprehensive services for first-in-human, matched to your molecule

Explore Mammalian >>

kbi-sub-pg-sb-ma

Microbial 

Raising the bar on microbial expression and manufacturability

Explore Microbial >>

kbi-sub-pg-sb-mi

Cell Therapy 

Supporting unique autologous and allogeneic therapeutic development.

Explore Cell Therapy >>

kbi-sub-pg-sb-ct

Analytical 

Developing lasting solutions to analytical challenges in biologics

Explore Analytical >>

kbi-sub-pg-sb-an

Latest News from KBI Biopharma

As the icon of next-generation CDMOs, KBI is driving breakthroughs in Biopharmaceutical Development and Manufacturing to positively impact patients' lives around the world. 

 

Read the Latest Releases

Featured Resources

microbial-whitepaper
Whitepaper:

Navigating a New Standard in Microbial Protein Expression

Download the Whitepaper

mass-spec
Article:

Using Advanced Mass Spectrometry for Characterization and Quantitation of APIs and Impurities in Complex Biotherapeutics

Read the Article

bispecific-webinar
Webinar:

Streamlined Development For Efficient Production Of Bispecific Molecules Using An Integrated Platform Process

Watch the Webinar

cell-therapy-article
Article:

Cell and Gene Therapies: Current Challenges and Promising Therapies on the Horizon

Read the Article

Never Miss Another Update! 

Subscribe to KBI's Newsletter, The Pulse, to stay up-to-date on all the latest news, articles, and events from KBI Biopharma.